Changing the way lung cancer is treated
Clinic to bench: Translating patient’s disease to treatment
Identification of new oncogenic drivers and resistance mechanisms
Exploiting cutting edge technologies to improve patient outcome
Development of new targeted therapies
Understanding minimal residual disease (MRD)
